On 20 Nov 2025, Checkpoint Trends opened at Rs.88.17 and maintained this price throughout the trading session, underscoring a day of stability at peak levels. The stock outperformed its sector by 2.3% and recorded a day gain of 1.99%, notably surpassing the Sensex's 0.22% rise. This performance is part of a broader trend, with the stock gaining for 20 consecutive days, delivering a cumulative return of 48.36% during this period.
Checkpoint Trends currently trades above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a robust upward trend. This technical positioning supports the stock's recent strength and reflects positive market sentiment within the Pharmaceuticals & Biotechnology sector.
This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!
- - Precise target price set
- - Weekly selection live
- - Position check opportunity
Examining the stock's performance over various time frames reveals a striking outperformance relative to the Sensex. Over one week, Checkpoint Trends recorded a gain of 10.36%, compared to the Sensex's 1.06%. The one-month return stands at 45.40%, while the Sensex posted 1.20% in the same period. The three-month performance is particularly notable, with Checkpoint Trends registering a 132.39% rise against the Sensex's 4.30%.
Longer-term data further emphasises the stock's exceptional growth. Over the past year, Checkpoint Trends has delivered a return of 551.66%, dwarfing the Sensex's 10.05%. Year-to-date figures show a 575.63% gain for the stock, compared with the Sensex's 9.26%. Extending the horizon, the three-year return for Checkpoint Trends is 2029.71%, while the Sensex recorded 38.45%. Over five years, the stock's return reaches 4243.35%, significantly outpacing the Sensex's 94.56%. The ten-year performance culminates in an extraordinary 5980.69% gain, compared to the Sensex's 230.04%.
Considering Checkpoint Trends ? Wait! SwitchER has found potentially better options in Pharmaceuticals & Biotechnology and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Pharmaceuticals & Biotechnology + beyond scope
- - Top-rated alternatives ready
Checkpoint Trends operates within the Pharmaceuticals & Biotechnology industry, a sector that has witnessed considerable activity and investor focus in recent years. The company's market capitalisation grade stands at 4, reflecting its established presence and scale within the industry. The stock's consistent upward movement and ability to maintain levels above critical moving averages indicate a strong foothold in its sector.
While the stock's recent gains are impressive, it is important to consider these figures within the broader market context. The Sensex, representing the benchmark index, has shown more modest returns across all comparable periods. This contrast highlights Checkpoint Trends' distinctive market performance and the unique factors driving its valuation.
Checkpoint Trends' journey to this all-time high has been marked by steady appreciation, supported by favourable sector dynamics and company-specific developments. The stock's ability to sustain gains over multiple time frames suggests resilience and a degree of market confidence in its business model and growth prospects.
In summary, Checkpoint Trends' attainment of Rs.88.17 as its highest-ever price represents a significant achievement. The stock's performance metrics, spanning from daily to decadal periods, illustrate a pattern of sustained growth and sector outperformance. This milestone underscores the company's prominent role within the Pharmaceuticals & Biotechnology sector and its capacity to deliver substantial returns over time.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
